Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Robert G. Shanks"'
Autor:
Robert G. Shanks
Publikováno v:
American Heart Journal. 107:1065-1071
A review of studies of mexiletine, a class I antiarrhythmic drug, supports its use in patients with ventricular arrhythmias or in sinus rhythm. Studies include patients likely to receive the drug in clinccal use—patients with and without coronary d
Publikováno v:
American Heart Journal. 87:21-25
Autor:
William H. Waugh, Robert G. Shanks
Publikováno v:
Circulation Research. 8:871-888
The mechanism causing renal vascular flow to vary less than proportional to changes in arterial-venous pressure gradient, was studied in isolated dog kidneys perfused with whole blood and with cell-free colloidal solutions. This autoregulation of ren
Autor:
C.D. Kinney, J. M. Mccomb, A.A.J. Adgey, Gilbert MacKenzie, H.M. Dunn, Robert G. Shanks, N.P.S. Campbell
Publikováno v:
American heart journal. 110(2)
Four hundred two patients with suspected myocardial infarction seen within 6 hours of the onset of symptoms entered a double-blind randomized trial of lidocaine vs placebo. During the 1 hour after administration of the drug the incidence of ventricul
Publikováno v:
The American journal of cardiology. 29(5)
Bretylium produced ventricular dysrhythmias in anesthetized normal dogs. It abolished ventricular dysrhythmias induced by adrenaline in dogs respired with halothane and room air, or by ouabain, but only after an initial aggravation of the dysrhythmia
Publikováno v:
The American journal of cardiology. 28(5)
The threshold for electrically induced ventricular fibrillation was measured by external transthoracic shocks in dogs weighing from 18 to 35 kg, anesthetized with morphine and pentobarbitone. The duration of the vulnerable period was determined for s